Viewing StudyNCT00140400



Ignite Creation Date: 2024-05-05 @ 11:50 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00140400
Status: COMPLETED
Last Update Posted: 2005-09-01
First Post: 2005-08-30

Brief Title: Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine Allogeneic Prostate GVAX in Patients With Hormone-Refractory Prostate Cancer
Sponsor: Cell Genesys
Organization: Cell Genesys

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Keywords:
Name View
Prostate View
Cancer View
Advanced prostate cancer View
Metastatic View
Hormone-refractory View
GVAX View
Vaccine View
Allogeneic cells View